Although not reporting other than the relationship between stromal ER and PR expression and clinical outcome upon standard treatment in a retrospective, consecutive cohort, the results from this study encourage a revision of some earlier studies that demonstrated beneficial effects of tamoxifen treatment in patients with advanced pancreatic adenocarcinoma [15], in particular in women [16, 17]. The gene discussed is ESR1; the disease is pancreatic adenocarcinoma.